BlackRock Investment Management, LLC - IMMUNE PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

IMMUNE PHARMACEUTICALS INC's ticker is IMNP and the CUSIP is 45254C101. A total of 16 filers reported holding IMMUNE PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of IMMUNE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$1,000
-50.0%
3,2450.0%0.00%–
Q4 2015$2,000
-50.0%
3,2450.0%0.00%–
Q3 2015$4,000
-33.3%
3,2450.0%0.00%–
Q2 2015$6,000–3,245–0.00%–
 Download
Other shareholders

There were no reported owners of IMMUNE PHARMACEUTICALS INC in Q4 2015.

NameSharesValueWeighting ↓
View complete list of IMMUNE PHARMACEUTICALS INC shareholders